Cytokinetics Newsroom

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $62 to $120

Futu NewsDec 3 21:01

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), PTC Therapeutics (PTCT) and Vir Biotechnology (VIR)

TipRanksDec 3 18:52

Cytokinetics Price Target Maintained With a $72.00/Share by Needham

Dow JonesDec 2 23:23

Cytokinetics Analyst Ratings

BenzingaDec 2 23:13

Promising Prospects for Cytokinetics: Aficamten's Strong Phase 3 Results and Strategic Bayer Collaboration Drive Buy Rating

TipRanksDec 2 22:26

RBC Capital Sticks to Its Buy Rating for Cytokinetics (CYTK)

TipRanksNov 28 09:49

Cytokinetics Is Maintained at Outperform by Mizuho

Dow JonesNov 21 21:20

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $70 to $120

Futu NewsNov 20 21:01

Cytokinetics' Hold Rating Amid Bayer Partnership and Acquisition Uncertainty

TipRanksNov 20 19:18

Cytokinetics Gains 'Buy' Rating Due to Strategic Collaborations and Potential FDA Approval

TipRanksNov 20 05:07

Cytokinetics Analyst Ratings

BenzingaNov 20 01:46

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Futu NewsNov 19 16:42

Positive Clinical Outcomes Drive Buy Rating for Cytokinetics's Cardiac Myosin Modulators

TipRanksNov 18 19:21

Cytokinetics Analyst Ratings

BenzingaNov 12 00:02

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Futu NewsNov 11 22:33

RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $80

Futu NewsNov 11 20:34

Cytokinetics (CYTK) Initiated With a Buy at RBC Capital

TipRanksNov 11 19:51

Cytokinetics: Strategic Growth and Strong Financial Positioning Drive Buy Rating

TipRanksNov 11 14:31

Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $72

Futu NewsNov 9 19:34

RBC Starts Cytokinetics With Outperform Rating, $80 Price Target

MT NewswiresNov 8 21:52